Abstract
There is growing evidence highlighting the ability of nuclear receptors to control not only metabolism, but also inflammation and cancer progression. In particular liver X receptors (LXRs), the nuclear receptors physiologically involved in cholesterol homeostasis, have been shown to regulate innate and adaptive immune responses in many pathological conditions, including cancer.
We have recently demonstrated that LXR ligands (oxysterols) released by tumor cells may have an immunomodulatory role, affecting the immune cells involved in the antitumor immune response. Indeed, oxysterols inhibit the expression of the chemokine receptor CCR7 on dendritic cells (DC) in an LXR-dependent manner, thus impairing DC migration to secondary lymphoid organs, and therefore dampening the induction of successful antitumor responses.
We have resorted to direct (i.e., luciferase-based LXR activation assay) and indirect (i.e., activation of LXR target genes in dendritic cells) methods in order to assess the presence of LXR ligands (oxysterols) in tumor-conditioned media.
These two methods are also suitable to study strategies to block oxysterol release by tumor cells.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Yang X, Lamia KA, Evans RM (2007) Nuclear receptors, metabolism, and the circadian clock. Cold Spring Harb Symp Quant Biol 72:387–394
Kalaany NY, Mangelsdorf DJ (2006) LXRS and FXR: the yin and yang of cholesterol and fat metabolism. Annu Rev Physiol 68:159–191
Traversari C, Russo V (2012) Control of the immune system by oxysterols and cancer development. Curr Opin Pharmacol 12:729–735
Peet DJ, Janowski BA, Mangelsdorf DJ (1998) The LXRs: a new class of oxysterol receptors. Curr Opin Genet Dev 8:571–575
Bjorkhem I (2002) Do oxysterols control cholesterol homeostasis? J Clin Invest 110:725–730
Murphy RC, Johnson KM (2008) Cholesterol, reactive oxygen species, and the formation of biologically active mediators. J Biol Chem 283:15521–15525
Mast N, Annalora AJ, Lodowski DT et al (2011) Structural basis for three-step sequential catalysis by the cholesterol side chain cleavage enzyme CYP11A1. J Biol Chem 286:5607–5613
Glass CK, Rosenfeld MG (2000) The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev 14:121–141
Jakobsson T, Treuter E, Gustafsson JA et al (2012) Liver X receptor biology and pharmacology: new pathways, challenges and opportunities. Trends Pharmacol Sci 33:394–404
Bensinger SJ, Tontonoz P (2008) Integration of metabolism and inflammation by lipid-activated nuclear receptors. Nature 454:470–477
Joseph SB, Bradley MN, Castrillo A et al (2004) LXR-dependent gene expression is important for macrophage survival and the innate immune response. Cell 119:299–309
Valledor AF, Hsu LC, Ogawa S et al (2004) Activation of liver X receptors and retinoid X receptors prevents bacterial-induced macrophage apoptosis. Proc Natl Acad Sci U S A 101:17813–17818
A-Gonzalez N, Bensinger SJ, Hong C et al (2009) Apoptotic cells promote their own clearance and immune tolerance through activation of the nuclear receptor LXR. Immunity 31:245–258
Bensinger SJ, Bradley MN, Joseph SB et al (2008) LXR signaling couples sterol metabolism to proliferation in the acquired immune response. Cell 134:97–111
Walcher D, Kummel A, Kehrle B et al (2006) LXR activation reduces proinflammatory cytokine expression in human CD4-positive lymphocytes. Arterioscler Thromb Vasc Biol 26:1022–1028
Cui G, Qin X, Wu L et al (2011) Liver X receptor (LXR) mediates negative regulation of mouse and human Th17 differentiation. J Clin Invest 121:658–670
Villablanca EJ, Raccosta L, Zhou D et al (2010) Tumor-mediated liver X receptor-alpha activation inhibits CC chemokine receptor-7 expression on dendritic cells and dampens antitumor responses. Nat Med 16:98–105
Hanley TM, Blay Puryear W, Gummuluru S et al (2010) PPARgamma and LXR signaling inhibit dendritic cell-mediated HIV-1 capture and trans-infection. PLoS Pathog 6:e1000981
Feig JE, Pineda-Torra I, Sanson M et al (2010) LXR promotes the maximal egress of monocyte-derived cells from mouse aortic plaques during atherosclerosis regression. J Clin Invest 120:4415–4424
Villablanca EJ, Zhou D, Valentinis B et al (2008) Selected natural and synthetic retinoids impair CCR7- and CXCR4-dependent cell migration in vitro and in vivo. J Leukoc Biol 84:871–879
Bergstrom JD, Kurtz MM, Rew DJ et al (1993) Zaragozic acids: a family of fungal metabolites that are picomolar competitive inhibitors of squalene synthase. Proc Natl Acad Sci U S A 90:80–84
Fuda H, Javitt NB, Mitamura K et al (2007) Oxysterols are substrates for cholesterol sulfotransferase. J Lipid Res 48:1343–1352
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media New York
About this protocol
Cite this protocol
Fontana, R., Paniccia, A., Russo, V. (2016). Detection and Functional Analysis of Tumor-Derived LXR Ligands. In: Bondanza, A., Casucci, M. (eds) Tumor Immunology. Methods in Molecular Biology, vol 1393. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-3338-9_5
Download citation
DOI: https://doi.org/10.1007/978-1-4939-3338-9_5
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-3336-5
Online ISBN: 978-1-4939-3338-9
eBook Packages: Springer Protocols